BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25011545)

  • 1. Myofibroblastic stromal reaction and lymph node status in invasive breast carcinoma: possible role of the TGF-β1/TGF-βR1 pathway.
    Catteau X; Simon P; Noël JC
    BMC Cancer; 2014 Jul; 14():499. PubMed ID: 25011545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variable stromal periductular expression of CD34 and smooth muscle actin (SMA) in intraductal carcinoma of the breast.
    Catteau X; Simon P; Vanhaeverbeek M; Noël JC
    PLoS One; 2013; 8(3):e57773. PubMed ID: 23469238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions.
    Barth PJ; Ebrahimsade S; Ramaswamy A; Moll R
    Virchows Arch; 2002 Mar; 440(3):298-303. PubMed ID: 11889601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of stromal myofibroblasts in invasive breast cancer: stromal expression of alpha-smooth muscle actin correlates with worse clinical outcome.
    Yamashita M; Ogawa T; Zhang X; Hanamura N; Kashikura Y; Takamura M; Yoneda M; Shiraishi T
    Breast Cancer; 2012 Apr; 19(2):170-6. PubMed ID: 20978953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myofibroblastic reaction is a common event in metastatic disease of breast carcinoma: a descriptive study.
    Catteau X; Simon P; Noël JC
    Diagn Pathol; 2014 Oct; 9():196. PubMed ID: 25339428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stromal remodeling and SPARC (secreted protein acid rich in cysteine) expression in invasive ductal carcinomas of the breast.
    Barth PJ; Moll R; Ramaswamy A
    Virchows Arch; 2005 May; 446(5):532-6. PubMed ID: 15838642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Significance of the Stromal Response in Breast Cancer: An Immunohistochemical Study of Myofibroblasts in Primary and Metastatic Breast Cancer.
    Roozdar A; Hayes MM; Pourseyedei B; Zeinalinejad H; Shamsi Meymandi M; Dabiri B; Dabiri S
    Arch Iran Med; 2018 May; 21(5):185-190. PubMed ID: 29738261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CD34, alpha-smooth muscle actin and transforming growth factor-beta1 in squamous intraepithelial lesions and squamous cell carcinoma of the cervix.
    Li Q; Huang W; Zhou X
    J Int Med Res; 2009; 37(2):446-54. PubMed ID: 19383239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic relevance of the loss of stromal CD34 positive fibroblasts in invasive lobular carcinoma of the breast.
    Westhoff CC; Jank P; Jacke CO; Albert US; Ebrahimsade S; Barth PJ; Moll R
    Virchows Arch; 2020 Nov; 477(5):717-724. PubMed ID: 32435886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological significance of stromal myofibroblasts in invasive ductal carcinoma of the breast.
    Yazhou C; Wenlv S; Weidong Z; Licun W
    Tumour Biol; 2004; 25(5-6):290-5. PubMed ID: 15627894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Jun N terminal kinase modulates NOX-4 derived ROS production and myofibroblasts differentiation in human breast stromal cells.
    Tobar N; Toyos M; Urra C; Méndez N; Arancibia R; Smith PC; Martínez J
    BMC Cancer; 2014 Aug; 14():640. PubMed ID: 25175743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of myofibroblast cells and microvessels around invasive ductal carcinoma of the breast and comparing with the adjacent range of their normal-to-DCIS zones.
    Dabiri S; Talebi A; Shahryari J; Meymandi MS; Safizadeh H
    Arch Iran Med; 2013 Feb; 16(2):93-9. PubMed ID: 23360631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of TGF-beta1 and the mechanism of invasiveness and metastasis induced by TGF-beta1 in breast cancer].
    Bao J; Wu ZS; Qi Y; Wu Q; Yang F
    Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):679-82. PubMed ID: 20021864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and secretion of TGF-beta isoforms and expression of TGF-beta-receptors I, II and III in normal and neoplastic human breast.
    Chakravarthy D; Green AR; Green VL; Kerin MJ; Speirs V
    Int J Oncol; 1999 Jul; 15(1):187-94. PubMed ID: 10375614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CD34, alpha-smooth muscle actin, and transforming growth factor beta1 in squamous intraepithelial lesions and squamous cell carcinoma of the larynx and hypopharynx.
    Kojc N; Zidar N; Vodopivec B; Gale N
    Hum Pathol; 2005 Jan; 36(1):16-21. PubMed ID: 15712177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD34(+) fibrocytes in normal cervical stroma, cervical intraepithelial neoplasia III, and invasive squamous cell carcinoma of the cervix uteri.
    Barth PJ; Ramaswamy A; Moll R
    Virchows Arch; 2002 Dec; 441(6):564-8. PubMed ID: 12461613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of stromal reaction in breast carcinoma and its correlation with tumor grade and free progression survival.
    Catteau X; Simon P; Jondet M; Vanhaeverbeek M; Noël JC
    PLoS One; 2019; 14(3):e0210263. PubMed ID: 30897102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD34(low) and SMA(high) represent stromal signature in uterine cervical cancer and are markers for peritumoral stromal remodeling.
    Horn LC; Schreiter C; Canzler A; Leonhardt K; Einenkel J; Hentschel B
    Ann Diagn Pathol; 2013 Dec; 17(6):531-5. PubMed ID: 24183311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD26 expression is attenuated by TGF-β and SDF-1 autocrine signaling on stromal myofibroblasts in human breast cancers.
    Mezawa Y; Daigo Y; Takano A; Miyagi Y; Yokose T; Yamashita T; Morimoto C; Hino O; Orimo A
    Cancer Med; 2019 Jul; 8(8):3936-3948. PubMed ID: 31140748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.